|
2010-04-21 |
Mebendazole compared with secnidazole-adult giardiasis-Phase III |
HMC_FINLAY |
Registered |
|
26/11/2020 |
MAMBISA Study |
CIGB |
Registered outdated |
|
2011-07-12 |
MAGINC Study |
CIGB |
Registered |
|
05/08/2021 |
Lithium Carbonate-COVID-19- mild and moderate -Exploratory / Phase II |
ICBPGirón |
Registered outdated |
|
2010-03-01 |
Lidoment - pain osteomioarticular - phase IV |
PUVEDADO |
Registered |
|
03/03/2023 |
Kardioli® nutritional supplement versus placebo in patients with chronic heart failure. Phase II. |
CATALYSIS |
Registered |
|
14/10/2022 |
Jusvinza in Severe Patients with Acquired Community Pneumonia |
CIGB |
Registered |
|
20/04/2022 |
Jusvinza in rheumatoid arthritis |
CIGB |
Registered |
|
27/02/2024 |
Jusvinza in adult patients with Rheumatoid Arthritis from Camaguey and Eastern Provinces |
CIGB_IB |
Registered |
|
06/01/2023 |
IVD in colon cancer |
HHA |
Registered |
|
30/06/2021 |
Itolizumab-Plasmapheresis in patients with COVID-19 |
CIM |
Registered |
|
26/03/2021 |
Itolizumab Safety and Efficacy Study in Covid 19 |
CIM |
Registered |
|
22/05/2015 |
Itolizumab for Relapsing Remitting Multiple Sclerosis |
CIM |
Registered |
|
08/10/2015 |
Itolizumab for Moderate-to-Severe Psoriasis-phase 3 |
CIM |
Registered |
|
23/12/2016 |
Itolizumab (T1h) combined with insulin in patients with Type I Diabetes Mellitus |
CIM |
Registered |
|
18/06/2021 |
ior®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders |
CIM |
Registered outdated |
|
2012-09-17 |
iorEPOCIM-Stroke-Phase I |
CIMAB |
Registered outdated |
|
26/08/2013 |
ior ®EPOCIM as a cardioprotective agent in the surgery of rheumatic valvular disease. |
CIMAB |
Registered outdated |
|
2013-02-26 |
ior EPOCIM ® in the management of anemia of the preterm infant.Phase IV. |
CIMAB |
Registered |
|
2013-01-17 |
Intravenous CIGB-128-A in patients with brain tumors (BRATINC Study) |
CIGB |
Registered |
